BACKGROUND: An N279K missense mutation in exon 10 of the tau gene reported in an American family with pallidopontonigral degeneration (PPND family) was recently found in members of a French kindred with dementia and supranuclear palsy. OBJECTIVES: To compare clinical phenotypes of both families and to perform genealogical and molecular genetic studies to determine whether they are derived from a common founder. DESIGN AND METHODS: We performed clinical examinations of affected members of both families and compared clinical phenotypes, existing genealogical family records, and chromosome 17 microsatellite repeat markers in the vicinity of the tau gene. RESULTS: The inheritance pattern is autosomal dominant in the PPND family and appears so in the French family. Average age at onset of clinical symptoms was 43 years in the PPND family and 41 years in the French family. Mean disease duration was 8 years in the PPND family and 6 years in the French family. Parkinsonism, personality changes, and dementia of the frontotemporal type were seen in both kindreds. All affected patients exhibited rapidly progressive parkinsonism characterized by bradykinesia, tremor, postural instability, and rigidity. Some had a transient response to levodopa therapy during the initial stages. Pyramidal signs and eye movement abnormalities, including supranuclear gaze palsy, were common. Results of linkage studies of the tau region in chromosome 17 did not reveal a haplotype common to both kindreds. CONCLUSIONS: Affected members from both families had more clinical similarities than differences. Results of genealogical and molecular genetic studies determined that the families were not related. The N279K mutations found in both families have independent origins.
BACKGROUND: An N279K missense mutation in exon 10 of the tau gene reported in an American family with pallidopontonigral degeneration (PPND family) was recently found in members of a French kindred with dementia and supranuclear palsy. OBJECTIVES: To compare clinical phenotypes of both families and to perform genealogical and molecular genetic studies to determine whether they are derived from a common founder. DESIGN AND METHODS: We performed clinical examinations of affected members of both families and compared clinical phenotypes, existing genealogical family records, and chromosome 17 microsatellite repeat markers in the vicinity of the tau gene. RESULTS: The inheritance pattern is autosomal dominant in the PPND family and appears so in the French family. Average age at onset of clinical symptoms was 43 years in the PPND family and 41 years in the French family. Mean disease duration was 8 years in the PPND family and 6 years in the French family. Parkinsonism, personality changes, and dementia of the frontotemporal type were seen in both kindreds. All affected patients exhibited rapidly progressive parkinsonism characterized by bradykinesia, tremor, postural instability, and rigidity. Some had a transient response to levodopa therapy during the initial stages. Pyramidal signs and eye movement abnormalities, including supranuclear gaze palsy, were common. Results of linkage studies of the tau region in chromosome 17 did not reveal a haplotype common to both kindreds. CONCLUSIONS: Affected members from both families had more clinical similarities than differences. Results of genealogical and molecular genetic studies determined that the families were not related. The N279K mutations found in both families have independent origins.
Authors: Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Maria Shiung; David S Knopman; Rosa Rademakers; Mike Hutton; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Ronald C Petersen Journal: Arch Neurol Date: 2010-02
Authors: Jonathan D Rohrer; Dominic Paviour; Jana Vandrovcova; John Hodges; Rohan de Silva; Martin N Rossor Journal: Neurodegener Dis Date: 2010-09-14 Impact factor: 2.977
Authors: Melissa C Wren; Jing Zhao; Chia-Chen Liu; Melissa E Murray; Yuka Atagi; Mary D Davis; Yuan Fu; Hirotaka J Okano; Kotaro Ogaki; Audrey J Strongosky; Pawel Tacik; Rosa Rademakers; Owen A Ross; Dennis W Dickson; Zbigniew K Wszolek; Takahisa Kanekiyo; Guojun Bu Journal: Mol Neurodegener Date: 2015-09-15 Impact factor: 14.195
Authors: Katerina Markopoulou; Bruce A Chase; Piotr Robowski; Audrey Strongosky; Ewa Narożańska; Emilia J Sitek; Mariusz Berdynski; Maria Barcikowska; Matt C Baker; Rosa Rademakers; Jarosław Sławek; Christine Klein; Katja Hückelheim; Meike Kasten; Zbigniew K Wszolek Journal: PLoS One Date: 2016-11-17 Impact factor: 3.240